It also inhibited the proliferation and tumor growth of the human A549 non-small-cell lung cancer (NSCLC) model due to the inhibition of PDGFR-β phosphorylation and downregulation of tumor VEGF expression [4,5]. Here, VEGFA is linked to non-small cell lung carcinoma.